GustavoAlvaMDDFAPA

Clinical Trials

• AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01

  Completed

  Phase 2, Phase 3

• A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease Start of enrollment: 2017 May 09

  Completed

  Phase 1, Phase 2

• Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type Start of enrollment: 2022 Nov 01

  Recruiting

  Phase 3

  Roles: Contact, Principal Investigator

• A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD Start of enrollment: 2021 Jun 21

  Completed

  Phase 1

  Roles: Contact, Principal Investigator

• Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease Start of enrollment: 2021 Nov 03

  Active, not recruiting

  Phase 3

  Roles: Principal Investigator, Contact

• Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease Start of enrollment: 2022 May 12

  Active, not recruiting

  Phase 2, Phase 3

  Roles: Contact

• ANC-501 in the Treatment of Adults With Major Depressive Disorder Start of enrollment: 2022 Sep 19

  Active, not recruiting

  Phase 2

  Roles: Principal Investigator, Contact

• Join now to see all